Segui
Luca Beltrame
Luca Beltrame
Senior Bioinformatician, IRCCS Humanitas Research Hospital
Email verificata su humanitasresearch.it
Titolo
Citata da
Citata da
Anno
Role of macrophage targeting in the antitumor activity of trabectedin
G Germano, R Frapolli, C Belgiovine, A Anselmo, S Pesce, M Liguori, ...
Cancer cell 23 (2), 249-262, 2013
8942013
Blood pressure variability and organ damage in a general population: results from the PAMELA study
R Sega, G Corrao, M Bombelli, L Beltrame, R Facchetti, G Grassi, ...
Hypertension 39 (2), 710-714, 2002
4512002
Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections
S Marchini, D Cavalieri, R Fruscio, E Calura, D Garavaglia, IF Nerini, ...
The lancet oncology 12 (3), 273-285, 2011
2192011
Pharmacological blockade of IL-1β/IL-1 receptor type 1 axis during epileptogenesis provides neuroprotection in two rat models of temporal lobe epilepsy
FM Noe, N Polascheck, F Frigerio, M Bankstahl, T Ravizza, S Marchini, ...
Neurobiology of disease 59, 183-193, 2013
1972013
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer
S Marchini, R Fruscio, L Clivio, L Beltrame, L Porcu, IF Nerini, D Cavalieri, ...
European journal of cancer 49 (2), 520-530, 2013
1872013
Blockade of the IL-1R1/TLR4 pathway mediates disease-modification therapeutic effects in a model of acquired epilepsy
V Iori, AM Iyer, T Ravizza, L Beltrame, L Paracchini, S Marchini, M Cerovic, ...
Neurobiology of disease 99, 12-23, 2017
1722017
Mode of action of trabectedin in myxoid liposarcomas
S Di Giandomenico, R Frapolli, E Bello, S Uboldi, SA Licandro, S Marchini, ...
Oncogene 33 (44), 5201-5210, 2014
1412014
Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion
V Santarlasci, L Maggi, M Capone, V Querci, L Beltrame, D Cavalieri, ...
Immunity 36 (2), 201-214, 2012
1382012
Lurbinectedin reduces tumour-associated macrophages and the inflammatory tumour microenvironment in preclinical models
C Belgiovine, E Bello, M Liguori, I Craparotta, L Mannarino, L Paracchini, ...
British journal of cancer 117 (5), 628-638, 2017
1332017
Inhibition of immune synapse by altered dendritic cell actin distribution: a new pathway of mesenchymal stem cell immune regulation
A Aldinucci, L Rizzetto, L Pieri, D Nosi, P Romagnoli, T Biagioli, ...
The Journal of Immunology 185 (9), 5102-5110, 2010
1282010
Bone marrow fibroblasts overexpress miR‐27b and miR‐214 in step with multiple myeloma progression, dependent on tumour cell‐derived exosomes
MA Frassanito, V Desantis, L Di Marzo, I Craparotta, L Beltrame, ...
The Journal of pathology 247 (2), 241-253, 2019
892019
The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus
R Vázquez, ME Riveiro, L Astorgues-Xerri, E Odore, K Rezai, E Erba, ...
Oncotarget 8 (5), 7598, 2017
872017
IL‐4‐induced gene 1 maintains high T ob1 expression that contributes to TCR unresponsiveness in human T helper 17 cells
V Santarlasci, L Maggi, A Mazzoni, M Capone, V Querci, MC Rossi, ...
European journal of immunology 44 (3), 654-661, 2014
862014
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile
I Cifola, R Spinelli, L Beltrame, C Peano, E Fasoli, S Ferrero, S Bosari, ...
Molecular cancer 7, 1-12, 2008
842008
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts
P Todeschini, E Salviato, L Paracchini, M Ferracin, M Petrillo, L Zanotti, ...
Cancer Letters 388, 320-327, 2017
782017
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities
E Calura, R Fruscio, L Paracchini, E Bignotti, A Ravaggi, P Martini, ...
Clinical cancer research 19 (15), 4114-4123, 2013
772013
Differential IL-17 production and mannan recognition contribute to fungal pathogenicity and commensalism
L Rizzetto, M Kuka, C De Filippo, A Cambi, MG Netea, L Beltrame, ...
The Journal of Immunology 184 (8), 4258-4268, 2010
762010
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
RA Tassi, P Todeschini, ER Siegel, S Calza, P Cappella, L Ardighieri, ...
Journal of Experimental & Clinical Cancer Research 36, 1-18, 2017
712017
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective …
M Petrillo, GF Zannoni, L Beltrame, E Martinelli, A DiFeo, L Paracchini, ...
Annals of Oncology 27 (4), 625-634, 2016
712016
Analysis of differential miRNA expression in primary tumor and stroma of colorectal cancer patients
G Della Vittoria Scarpati, E Calura, M Di Marino, C Romualdi, L Beltrame, ...
BioMed research international 2014, 2014
692014
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20